Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02617589
Brief Title: An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) (CheckMate 498)

First Submitted : November 26, 2015
First Submitted that Met QC Criteria : November 26, 2015
First Posted : December 1, 2015 (Estimate)

Results First Submitted : November 30, 2020
Results First Submitted that Met QC Criteria : January 15, 2021
Results First Posted : February 3, 2021

Certification/Extension First Submitted : January 16, 2020
Certification/Extension First Submitted that Met QC Criteria : January 22, 2020
Certification/Extension First Posted : January 29, 2020

Last Update Submitted that Met QC Criteria : January 15, 2021
Last Update Posted : February 3, 2021